Antiretroviral therapy coverage in Indonesia
Indonesia: Antiretroviral therapy coverage was 41.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Indonesia, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Indonesia recorded 41.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
The figure is up 32.3% on the previous year and up 310.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Indonesia peaked at 41.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Indonesia 131st out of 143 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Indonesia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 2.0% | +0.0% |
| 2008 | 3.0% | +50.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 5.0% | +25.0% |
| 2011 | 6.0% | +20.0% |
| 2012 | 7.0% | +16.7% |
| 2013 | 8.0% | +14.3% |
| 2014 | 10.0% | +25.0% |
| 2015 | 12.0% | +20.0% |
| 2016 | 14.0% | +16.7% |
| 2017 | 16.0% | +14.3% |
| 2018 | 19.0% | +18.8% |
| 2019 | 22.0% | +15.8% |
| 2020 | 25.0% | +13.6% |
| 2021 | 27.0% | +8.0% |
| 2022 | 29.0% | +7.4% |
| 2023 | 31.0% | +6.9% |
| 2024 | 41.0% | +32.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.1% | 0.0% | 4.0% | 10 |
| 2010s | 11.9% | 5.0% | 22.0% | 10 |
| 2020s | 30.6% | 25.0% | 41.0% | 5 |
Countries ranked near Indonesia
- 129 Egypt 45.0% compare
- 130 Gambia 44.0% compare
- 131 Bangladesh 41.0% compare
- 131 Mongolia 41.0% compare
- 134 Philippines 40.0% compare
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Indonesia?
- Antiretroviral therapy coverage in Indonesia was 41.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Indonesia?
- The highest recorded value was 41.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Indonesia?
- The lowest recorded value was 0.0% in 2000.
- How does Indonesia rank for antiretroviral therapy coverage?
- Indonesia ranks 131st out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Indonesia?
- Over the last ten years it is up 310.0%. The long-run trend across the full record is volatile.
- Where does this Indonesia data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.